Page 62 - Product Testing News Today

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Press release content from PR Newswire. The AP news staff was not involved in its creation. VISEN Pharmaceuticals Receives IND Approval to Initiate Phase 2 Clinical Trial of TransCon ™ CNP in Achondroplasia (ACH) in China January 7, 2021 GMT SHANGHAI, Jan. 7, 2021 /PRNewswire/ -- VISEN Pharmaceuticals, a biotech company committed to the treatment of endocrine-related diseases, introducing the world’s leading treatment methods and drugs into the China market and hoping to provide more Chines...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Press release content from Business Wire. The AP news staff was not involved in its creation.

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Kamada Selected as a Winner of the Genesis Prize Foundation and Start-Up Nation Central Competition Kamada Ltd.January 5, 2021 GMT REHOVOT, Israel, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ & TASE: KMDA), plasma-derived biopharmaceutical company, today announced that it has been selected as one of 10 winners of the Genesis Prize Foundation (GPF) Start-Up Nation Central (SNC) competition re...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Tonix Pharmaceuticals and Massachusetts General Hospital (MGH) Enter into Research ... Tonix Pharmaceuticals Holding Corp.January 5, 2021 GMT Expands Ongoing Research Collaboration Between Tonix and MGH Studying TNX-1500 in Heart Transplantation TNX-1500 May Hold Potential in Treating Autoimmune Diseases Including Systemic Lupus Erythematosus, Rheumatoid Arthritis and Multiple Sclerosis CHATHAM, N.J.,...

Press release content from Accesswire. The AP news staff was not involved in its creation. Abivax Publishes Review in Drug Discovery Today on Mechanism of Action and Transformative Potential of ABX464 as Therapy for Inflammatory Diseases January 5, 2021 GMT Scientific review summarizes the molecular events leading to potent anti-inflammatory effects of lead molecule ABX464, centered around the specific upregulation of microRNA-124 (miR-124) Scientific data underpins ABX464′s potential to trea...

Press release content from Business Wire. The AP news staff was not involved in its creation. Frequency Therapeutics to Present 2021 Business and Pipeline Overview at the 39th Annual J.P. Morgan Healthcare Conference January 5, 2021 GMT WOBURN, Mass.--(BUSINESS WIRE)--Jan 5, 2021-- Frequency Therapeutics, Inc. (Nasdaq: FREQ), a clinical-stage biotechnology company focused on harnessing the body’s innate biology to repair or reverse damage caused by a broad range of degenerative diseases, toda...

Press release content from Business Wire. The AP news staff was not involved in its creation. Audentes Therapeutics Announces FDA Lifts Hold on ASPIRO Clinical Trial of AT132 for Treatment of X-Linked Myotubular Myopathy (XLMTM) December 24, 2020 GMT SAN FRANCISCO--(BUSINESS WIRE)--Dec 24, 2020-- Audentes Therapeutics, an Astellas genetic medicines company, today announced that the U.S. Food and Drug Administration (FDA) has lifted the clinical hold for the ASPIRO clinical trial evaluating AT13...